Kimia Bioscien.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE285U01025
NSEID:
BSEID: 530313
View on BSE

INR

31.47

-0.63 (-1.96%)

BSENSE

Jul 28, 04:00 PM

BSE+NSE Vol: 206

{
  "main_header": {
    "sid": 263659,
    "name": "Kimia Bioscien.",
    "stock_name": "Kimia Bioscien.",
    "full_name": "Kimia Biosciences Ltd",
    "name_url": "stocks-analysis/kimia-bioscien",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.47",
    "chg": -0.63,
    "chgp": "-1.96%",
    "dir": -1,
    "prev_price": "32.10",
    "mcapval": "148.89 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530313,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE285U01025",
    "curr_date": "Jul 28, 04:00 PM",
    "curr_time": "16:03 PM",
    "last_traded_at": "Jul 28, 04:00 PM IST",
    "bse_nse_vol": "206 ",
    "exc_status": "Active",
    "traded_date": "Jul 28, 2026",
    "traded_date_str": "2026 07 28",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kimia-bioscien-263659-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kimia Biosciences Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-4123553",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KimiaBioscience_mojoScore_4123553.png",
        "date": "2026-07-28 08:11:00",
        "description": "Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 27 Jul 2026, reflecting deteriorating fundamentals and a shift to bearish technical indicators. The micro-cap pharmaceutical company’s financial performance has weakened significantly, while valuation and technical trends have also contributed to the negative outlook."
      },
      {
        "title": "Kimia Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4114588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KimiaBioscience_mojoScore_4114588.png",
        "date": "2026-07-22 08:07:47",
        "description": "Kimia Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook amid persistent fundamental challenges. While the company’s financial performance remains under pressure, recent technical indicators have improved, prompting a reassessment of its near-term prospects."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-4112488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KimiaBioscience_mojoScore_4112488.png",
        "date": "2026-07-21 10:10:04",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 June 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 21 July 2026, providing investors with the latest view of the company’s position in the market."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-4096370",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KimiaBioscience_mojoScore_4096370.png",
        "date": "2026-07-10 10:10:30",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-4076960",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KimiaBioscience_mojoScore_4076960.png",
        "date": "2026-06-29 10:10:26",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kimia Biosciences Downgraded to Strong Sell Amid Weak Financials and Technical Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-downgraded-to-strong-sell-amid-weak-financials-and-technical-setbacks-4060523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KimiaBioscience_mojoScore_4060523.png",
        "date": "2026-06-18 08:05:52",
        "description": "Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, persistent financial weakness, and a shift in technical momentum, signalling heightened risks for investors in this micro-cap pharmaceutical company."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-sell-4054218",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KimiaBioscience_mojoScore_4054218.png",
        "date": "2026-06-15 10:10:37",
        "description": "Kimia Biosciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 3 June 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kimia Biosciences Ltd Falls 3.84%: 2 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-ltd-falls-384-2-key-factors-driving-the-weekly-decline-4053073",
        "imagepath": "",
        "date": "2026-06-14 14:01:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Stock opens sharply lower at Rs.33.29 (-8.79%) amid broad market weakness</p>\n                    <p><strong>2 June:</strong> Formation of Golden Cross signals potential bullish breakout despite price decline</p>\n                    <p><strong>4 June:</strong> MarketsMOJO downgrades rating from Strong Sell to Sell citing financial deterioration</p>\n                    <p><strong>5 June:</strong> Stock rebounds to Rs.35.10 (+6.01%) on increased volume but closes below week open</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.36.50</div></..."
      },
      {
        "title": "Kimia Biosciences Ltd Downgraded to Sell Amid Financial and Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-downgraded-to-sell-amid-financial-and-technical-shifts-4035386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KimiaBioscience_mojoScore_4035386.png",
        "date": "2026-06-04 08:07:12",
        "description": "Kimia Biosciences Ltd has seen its investment rating downgraded from Strong Sell to Sell as of 3 June 2026, reflecting deteriorating financial performance and mixed technical signals. Despite a modest uptick in daily share price, the company faces significant challenges across quality, valuation, financial trends, and technical indicators, prompting a reassessment of its market standing within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 204,
    "sid": "263659",
    "stock_news_url": "https://www.marketsmojo.com/news/kimia-biosciences-263659"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Jun-2026",
      "details": "Closure of Trading window for quarter ending June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Jun-2026",
      "details": "Publication of Results for quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of The Board Meeting Held On 29 May 2026",
      "datetime": "29-May-2026",
      "details": "Approval of Audited standalone Financial results alongwith Audited Report thereon for financial year 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kimia Biosciences Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-07-28 08:11:00

Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 27 Jul 2026, reflecting deteriorating fundamentals and a shift to bearish technical indicators. The micro-cap pharmaceutical company’s financial performance has weakened significantly, while valuation and technical trends have also contributed to the negative outlook.

Read full news article

Kimia Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-07-22 08:07:47

Kimia Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook amid persistent fundamental challenges. While the company’s financial performance remains under pressure, recent technical indicators have improved, prompting a reassessment of its near-term prospects.

Read full news article

Kimia Biosciences Ltd is Rated Strong Sell

2026-07-21 10:10:04

Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 June 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 21 July 2026, providing investors with the latest view of the company’s position in the market.

Read full news article

Kimia Biosciences Ltd is Rated Strong Sell

2026-07-10 10:10:30

Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Kimia Biosciences Ltd is Rated Strong Sell

2026-06-29 10:10:26

Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Kimia Biosciences Downgraded to Strong Sell Amid Weak Financials and Technical Setbacks

2026-06-18 08:05:52

Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, persistent financial weakness, and a shift in technical momentum, signalling heightened risks for investors in this micro-cap pharmaceutical company.

Read full news article

Kimia Biosciences Ltd is Rated Sell

2026-06-15 10:10:37

Kimia Biosciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 3 June 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Kimia Biosciences Ltd Falls 3.84%: 2 Key Factors Driving the Weekly Decline

2026-06-14 14:01:25

Key Events This Week

1 June: Stock opens sharply lower at Rs.33.29 (-8.79%) amid broad market weakness

2 June: Formation of Golden Cross signals potential bullish breakout despite price decline

4 June: MarketsMOJO downgrades rating from Strong Sell to Sell citing financial deterioration

5 June: Stock rebounds to Rs.35.10 (+6.01%) on increased volume but closes below week open

Week Open

Rs.36.50

Read full news article

Kimia Biosciences Ltd Downgraded to Sell Amid Financial and Technical Shifts

2026-06-04 08:07:12

Kimia Biosciences Ltd has seen its investment rating downgraded from Strong Sell to Sell as of 3 June 2026, reflecting deteriorating financial performance and mixed technical signals. Despite a modest uptick in daily share price, the company faces significant challenges across quality, valuation, financial trends, and technical indicators, prompting a reassessment of its market standing within the Pharmaceuticals & Biotechnology sector.